Inherited RET activating mutations are associated with MTC, either alone (familial medullary thyroid cancer [FMTC]) or as part of the multiple endocrine neoplasia type 2A (MEN 2A) or MEN 2B syndromes [23]. The gene discussed is RET; the disease is medullary thyroid gland carcinoma.